PeptideNerds
· GLP-1 Receptor Agonists · 12 min read

GLP-1 and Anesthesia: The Pre-Surgery Protocol Every Ozempic User Needs to Know

Alejandro Reyes

Written by Alejandro Reyes

Founder & Lead Researcher

PN

Reviewed by Peptide Nerds Editorial · Updated April 2026

GLP-1 and Anesthesia: The Pre-Surgery Protocol Every Ozempic User Needs to Know

Most people on semaglutide or tirzepatide know the drill: inject once a week, eat less, lose weight. What almost nobody tells them is that these drugs change how your stomach empties food — and that fact becomes genuinely dangerous when you go under general anesthesia.

This is not a rare edge case. Millions of people are on GLP-1 receptor agonists right now, and surgeries happen every day. The protocol for handling this safely has evolved fast in the last two years, and most patients are still hearing nothing about it from their prescribers.

Important: I'm not a doctor. Everything here is based on published research and emerging clinical guidance. Talk to your anesthesiologist and prescribing physician before making any changes ahead of a procedure.


The Bottom Line

  • GLP-1 medications like Ozempic, Wegovy, and Mounjaro significantly slow how fast your stomach empties. This is part of how they work — but it creates a real aspiration risk under anesthesia.
  • Standard fasting rules (nothing after midnight) may not be enough protection if you're on a GLP-1. Your stomach may still have food or liquid in it even after a full overnight fast.
  • Published research supports using bedside gastric ultrasound before anesthesia to actually see how much is in your stomach — not just assume it's empty.
  • The most actionable step you can take right now: tell your surgical team you're on a GLP-1 before your procedure date, and ask specifically about gastric ultrasound assessment and adjusted fasting protocols.
  • Most anesthesia societies now recommend pausing weekly GLP-1 injections at least 1 week before elective surgery. Some clinicians extend this to 2 weeks for higher-risk patients.

Why GLP-1 Drugs and Anesthesia Are a Dangerous Combination

Here is the basic problem. GLP-1 receptor agonists slow down gastric emptying. That is actually a feature — it is part of why you feel full longer and eat less. Your stomach holds onto food, signals satiety to your brain, and you naturally consume fewer calories.

Under general anesthesia, though, your airway reflexes go offline. If there is still food or liquid sitting in your stomach, it can come back up and get inhaled into your lungs. That is called aspiration, and it can cause a serious pneumonia or, in worst-case scenarios, become life-threatening.

The standard protection against this is fasting before surgery. You stop eating and drinking for a set number of hours so your stomach is empty when the anesthesiologist puts you under. The problem is that the standard fasting windows were designed before GLP-1 drugs existed.

A 2024 study published in the journal Regional Anesthesia & Pain Medicine examined gastric content in patients on GLP-1 receptor agonists before anesthesia and found that these patients had significantly higher rates of "full stomach" status — even after following standard pre-operative fasting instructions.

In plain English: following the rules wasn't enough.


What the Research Actually Shows About Gastric Emptying on GLP-1s

GLP-1 medications do not slow gastric emptying by a little. Studies show they can extend the time food stays in your stomach by 30–70% compared to baseline, depending on the drug, the dose, and the individual.

Weekly injectable formulations like semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound) have longer-lasting effects than daily injectables or older oral versions. Because they stay active in your system for the full week between doses, the gastric-slowing effect is essentially continuous — it does not wear off overnight.

This is what makes the anesthesia risk particularly tricky. Even if you followed the 8-hour fast, even if you ate light the night before, there is a real possibility your stomach has not fully emptied.

The American Society of Anesthesiologists (ASA) issued guidance in 2023 acknowledging this risk, and updated recommendations have followed from multiple anesthesia societies worldwide. The core message: patients on GLP-1 agents need individualized pre-operative assessment, not just the standard fasting protocol.


The Gastric Ultrasound Solution: What It Is and Why It Matters

This is where the practical protocol gets interesting. There is a simple bedside tool that can actually show what is in your stomach before you go under: point-of-care gastric ultrasound.

This is not a complex procedure. An anesthesiologist or trained clinician places an ultrasound probe on your abdomen in two positions — lying flat on your back and on your right side — and looks at the antrum of the stomach (the lower portion). They can see whether it looks empty, whether there is clear liquid, or whether there is solid content still sitting there.

Studies have shown this technique to be highly accurate for classifying gastric content before anesthesia. A 2023 review in Anesthesiology supports gastric ultrasound as a reliable method for identifying "at-risk" patients who may require modified anesthetic management — including awake intubation or rapid sequence induction techniques that reduce aspiration risk.

Here is what the ultrasound findings mean in practice:

  • Empty antrum: Low risk. Standard induction is typically appropriate.
  • Clear fluid only (small volume): Generally acceptable. Anesthesiologist uses clinical judgment.
  • Solid content or large fluid volume: High risk. The surgical team adjusts the approach — or in elective cases, may delay the procedure.

For patients on GLP-1 medications, this pre-check has gone from "optional advanced technique" to something many anesthesiologists now consider standard care.


The Step-by-Step Pre-Surgery Protocol for GLP-1 Users

Here is the most practical part of this article. If you are on a GLP-1 medication and have a procedure coming up — elective or otherwise — here is exactly what you should do.

Step 1: Disclose Your GLP-1 Use Immediately

Tell your surgeon's office and anesthesiologist that you are on a GLP-1 receptor agonist. Do this at your pre-operative appointment, not the morning of surgery. Include the drug name, dose, and how long you have been taking it.

Do not assume it is in your chart. Do not assume the anesthesiologist will check. Tell them directly.

Step 2: Ask About Pausing Your Medication Before Surgery

Current guidance from the ASA and the European Society of Anaesthesiology recommends pausing weekly GLP-1 injections for at least 1 full week before elective procedures. Some clinicians recommend 2 weeks for patients on higher doses or those with known gastroparesis symptoms (bloating, feeling full hours after eating, nausea).

For daily GLP-1 formulations, the recommendation is typically 1 day of pause before surgery.

This pause allows gastric motility to begin returning toward baseline. It does not eliminate the risk entirely, but it meaningfully reduces it.

Do not stop your medication without your prescriber's sign-off. For people managing type 2 diabetes, pausing a GLP-1 needs a blood sugar management plan in place for that week.

Step 3: Follow an Extended Fasting Protocol

Standard fasting is "nothing to eat for 8 hours, clear liquids up to 2 hours before." For GLP-1 patients, many anesthesiologists now use a stricter window:

  • Solid food: 8–12 hours before the procedure (some centers go to 12 hours as default)
  • Clear liquids: Stop 4 hours before rather than the standard 2 hours
  • Avoid high-fat, high-protein meals in the 24 hours before surgery — these are the slowest to empty even in non-GLP-1 patients

Ask your surgical team what their specific protocol is. Some centers have formalized this for GLP-1 patients; others are still using general guidelines.

Step 4: Request Gastric Ultrasound Before Induction

This is your right as a patient. Before going under, you can ask your anesthesiologist whether they will assess gastric content via bedside ultrasound.

Not every facility has this capability, but it is increasingly common in hospitals and surgical centers that handle high volumes of patients. If your center does not offer it, at minimum make sure your anesthesia team knows your GLP-1 status and the associated risk.

If the ultrasound shows residual gastric content, your team can:

  • Delay an elective procedure
  • Use rapid sequence induction (RSI) — a faster intubation technique that reduces the window for aspiration
  • Consider awake fiberoptic intubation in high-risk cases

Step 5: Know the Warning Signs of Gastroparesis

Some people on GLP-1 medications develop symptoms that suggest more significant gastric slowing — a condition called gastroparesis. If you experience any of these regularly, flag them to your surgical team before your procedure:

  • Feeling full for hours after a small meal
  • Chronic nausea or bloating
  • Vomiting undigested food
  • Early satiety that feels extreme even compared to your usual GLP-1 effects

These symptoms suggest your gastric emptying may be significantly impaired beyond the typical GLP-1 effect. This is a higher-risk category and warrants extra pre-operative caution.


Common Mistakes to Avoid

Mistake 1: Assuming your prescriber told your surgical team. They probably did not. This information does not always transfer automatically. You are the bridge between these providers — own it.

Mistake 2: Stopping your GLP-1 without a plan for your blood sugar. If you have type 2 diabetes, stopping your GLP-1 for a week requires coverage. Work with your prescriber to have a plan.

Mistake 3: Thinking "I ate light" is good enough. The research is clear that subjective food choices do not reliably predict gastric content in GLP-1 users. The drugs change your physiology, not just your appetite.

Mistake 4: Not asking about gastric ultrasound. Many patients do not know this tool exists. Asking about it is not being difficult — it is being an informed patient. A good anesthesiologist will appreciate it.

Mistake 5: Applying this only to general anesthesia. Deep sedation and even heavy IV sedation carry similar aspiration risks. This protocol applies to colonoscopies, endoscopies, oral surgery under sedation, and any procedure where you lose your airway reflexes — not just full surgical cases.


What Anesthesiologists Are Doing Differently in 2026

The field has moved meaningfully on this. A few developments worth knowing:

More anesthesia departments are now adding GLP-1 status to pre-operative screening forms, right alongside questions about sleep apnea and prior anesthesia reactions. Gastric ultrasound is being incorporated into pre-anesthesia checklists at larger academic medical centers.

Research published via PubMed continues to support the gastric ultrasound approach as the most reliable bedside method for directly assessing aspiration risk in this population — more reliable than asking "when did you last eat?"

Some centers are also piloting prokinetic medications (drugs that speed gastric emptying) as a pre-operative strategy in GLP-1 patients, though this is still being studied and is not yet standard practice.


FAQ

Do I have to stop Ozempic before surgery? Most major anesthesia societies now recommend pausing weekly GLP-1 injections like semaglutide (Ozempic/Wegovy) for at least one week before elective surgery. This is not universal yet — your anesthesiologist and prescriber make the final call. Always check with both before stopping any medication.

Is gastric ultrasound available at every hospital? Not yet, but it is increasingly common. Most large hospitals and academic medical centers have anesthesiologists trained in point-of-care ultrasound. Smaller outpatient surgical centers may not. Ask in advance.

What if my surgery is not elective — it's an emergency? Emergency surgeries cannot wait. In this case, your anesthesiologist will treat you as a "full stomach" patient regardless of fasting status and use protective intubation techniques like rapid sequence induction. Make sure ER or OR staff know you are on a GLP-1 immediately.

Does this apply to tirzepatide (Mounjaro/Zepbound) too? Yes. Tirzepatide is a dual GIP/GLP-1 receptor agonist and has similar effects on gastric emptying. The same pre-operative precautions apply.

Can I resume my GLP-1 after surgery? Generally yes, once you are eating and tolerating food normally post-procedure. Your prescriber will advise on timing. There is no standard "resume after X days" rule — it depends on the surgery, recovery, and your individual situation.


The Bottom Line and Your Next Step

If you are on a GLP-1 medication and you have any procedure coming up — even a routine one under sedation — the single most important thing you can do is have a direct conversation with your anesthesiologist before the day of surgery.

Tell them you are on a GLP-1. Ask about an adjusted fasting protocol. Ask about gastric ultrasound assessment. Ask whether you should pause your medication in advance.

This is not about scaring yourself. It is about giving your surgical team the information they need to protect you. The research is clear that standard pre-operative assumptions do not fully account for how GLP-1 drugs change your stomach's behavior. The tools to manage this risk exist — you just have to make sure they get used.


Medical Disclaimer: The information on this website is for educational and informational purposes only. It is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any peptide protocol, medication, or supplement regimen. Individual results vary. The author shares personal experience and published research — not medical recommendations.


Sources

  1. Assessment of gastric content in patients on GLP-1 receptor agonists before anesthesia — PubMed, 2024
  2. GLP-1 Receptor Agonists — overview and mechanisms — PubMed, 2026
  3. American Society of Anesthesiologists Guidance on GLP-1 Agents and Perioperative Management — ASA, 2023
  4. Point-of-care gastric ultrasound as a pre-anesthesia assessment tool — Regional Anesthesia & Pain Medicine, 2024
  5. Renal Outcomes of GLP-1 Receptor Agonists and Tirzepatide — Scoping Review — PubMed, 2026

Free Peptide Weight Loss Guide

Semaglutide vs. tirzepatide vs. retatrutide. Dosing protocols, side effects, gray market sourcing, and what the clinical trials found.